JP2004502634A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004502634A5 JP2004502634A5 JP2001516551A JP2001516551A JP2004502634A5 JP 2004502634 A5 JP2004502634 A5 JP 2004502634A5 JP 2001516551 A JP2001516551 A JP 2001516551A JP 2001516551 A JP2001516551 A JP 2001516551A JP 2004502634 A5 JP2004502634 A5 JP 2004502634A5
- Authority
- JP
- Japan
- Prior art keywords
- substrate
- description
- composition
- treatment
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 description 17
- 239000000758 substrate Substances 0.000 description 16
- 238000004519 manufacturing process Methods 0.000 description 12
- 239000002537 cosmetic Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 210000003491 skin Anatomy 0.000 description 7
- 239000003886 aromatase inhibitor Substances 0.000 description 5
- 229940011871 estrogen Drugs 0.000 description 5
- 239000000262 estrogen Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 229940122815 Aromatase inhibitor Drugs 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 239000003862 glucocorticoid Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 229940037128 systemic glucocorticoids Drugs 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 2
- 229940113178 5 Alpha reductase inhibitor Drugs 0.000 description 2
- 239000002677 5-alpha reductase inhibitor Substances 0.000 description 2
- 102000014654 Aromatase Human genes 0.000 description 2
- 108010078554 Aromatase Proteins 0.000 description 2
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 229960003473 androstanolone Drugs 0.000 description 2
- 229940046836 anti-estrogen Drugs 0.000 description 2
- 230000001833 anti-estrogenic effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000328 estrogen antagonist Substances 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 229940046844 aromatase inhibitors Drugs 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 210000000746 body region Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2000/007315 WO2001012206A2 (de) | 1999-08-13 | 2000-07-28 | Soja-glycine extracten und aromatase-hemendern zur positiven beeinflussung von kollagen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004502634A JP2004502634A (ja) | 2004-01-29 |
| JP2004502634A5 true JP2004502634A5 (https=) | 2007-09-27 |
Family
ID=30775769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001516551A Pending JP2004502634A (ja) | 2000-07-28 | 2000-07-28 | コラーゲンにプラス方向に影響を与えるための基質および薬剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2004502634A (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100656807B1 (ko) * | 2005-02-23 | 2006-12-13 | 배석년 | 구연산, 아연 및 아르기닌으로 이루어진 팽창선조 예방 및치료용 조성물 |
| DE102008012988A1 (de) | 2008-03-07 | 2009-09-10 | S.W. Patentverwertungs Ltd. | Zusammensetzung und Verwendungen zur Beeinflussung des Haarwachstums |
| KR20140040690A (ko) * | 2011-01-31 | 2014-04-03 | 루콜라스-엠.디. 리미티드 | 미용학적 용도 |
| US11850451B2 (en) | 2011-01-31 | 2023-12-26 | Lucolas-M.D. Ltd. | Cosmetic compositions and methods for improving skin conditions |
| JP5872806B2 (ja) * | 2011-07-07 | 2016-03-01 | 花王株式会社 | Ｍｆａｐ−４産生促進剤 |
| JP6145181B2 (ja) * | 2016-01-14 | 2017-06-07 | 花王株式会社 | Ｍｆａｐ−４産生促進剤 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE59703511D1 (de) * | 1996-03-29 | 2001-06-13 | S W Patentverwaltungs Ges M B | Kosmetikum bzw. kosmetikzusammensetzung zur glättung und straffung der haut bei gestörtem unterhaut-binde-fettgewebe, insbesondere bei der "cellulite" |
-
2000
- 2000-07-28 JP JP2001516551A patent/JP2004502634A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1732577B1 (en) | Topical delivery of l-arginine to improve body and skin appearance | |
| US5629002A (en) | Cosmetic or pharmaceutic preparations for improving hair quaility and stimulating growth of the hair | |
| JP2001500841A (ja) | 障害された皮下結合脂肪組織、とりわけ脂肪性浮腫の場合における皮膚を引きしめ滑らかにするための化粧品および化粧用組成物 | |
| JP2004526758A5 (https=) | ||
| TW200505490A (en) | Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin | |
| JP2006515328A (ja) | 哺乳類の発毛の調節 | |
| WO2004043469A1 (en) | Anti-aging skin care composition and uses thereof | |
| CN102159179A (zh) | 防止、治疗脱发或促进毛发生成的成分 | |
| JP2007534751A5 (https=) | ||
| JPWO2019149450A5 (https=) | ||
| CA2564399A1 (en) | Use of equol for treating skin diseases | |
| JP2004502634A5 (https=) | ||
| CN104203230A (zh) | 抗拉伸纹皮肤乳膏及其制造和使用方法 | |
| US20040018991A1 (en) | Topical treatment for mastalgia | |
| CA2426467A1 (en) | Composition comprising 8-prenylnaringenin for treatment of skin | |
| JP2004532268A (ja) | 異常な角質性物質を除去するための製剤 | |
| CN102441006B (zh) | 一种含二氧化氯的生发溶液及其制备和使用方法 | |
| KR970703142A (ko) | 신전성 선조를 치료하기 위해 알파 히드록시산을 도포시키는 방법(applying alpha hydroxy acids for striae distensae) | |
| US5789445A (en) | Method for topical treatment of scar tissue and related tissue reaction to trauma | |
| US5939457A (en) | Method for reducing skin wrinkles and regulating skin atrophy | |
| RU2004119850A (ru) | Композиция на основе сложного диосгенина для топического нанесения | |
| JP2006524199A (ja) | 美容的ピーリング方法 | |
| US6461596B1 (en) | Composition and method for promoting hair growth | |
| WO2006068715A2 (en) | Cosmetic compositions having carnitine creatinate and methods for using | |
| Geetha | Skin and Menopause |